Updates on Prevention of Cardioembolic Strokes

Area of Science:

• Cardiology
• Neurology
• Medical Devices

Background:

• Cardiac embolism is a primary cause of ischemic stroke globally.
• While underlying causes remain consistent, stroke prevention and treatment have seen significant progress.
• Atrial fibrillation is the most common cause of cardioembolic strokes.

Purpose of the Study:

• To review recent advances in the diagnosis and management of cardioembolic stroke.
• To highlight new technologies and therapeutic strategies for stroke prevention.
• To discuss the evolving landscape of stroke risk assessment in various cardiac conditions.

Main Methods:

• Review of recent literature and clinical trial outcomes.
• Discussion of new diagnostic tools for atrial fibrillation detection.
• Analysis of emerging therapeutic interventions, including anticoagulants and device-based therapies.

Main Results:

• Improved detection of atrial fibrillation through long-term monitoring devices.
• Efficacy of non-vitamin K antagonist oral anticoagulants in preventing strokes in non-valvular atrial fibrillation.
• Introduction of left atrial appendage closure devices as a stroke prevention alternative.
• Clarification of patent foramen ovale closure's role in cryptogenic stroke prevention.
• New challenges in balancing ischemic and hemorrhagic risks with antithrombotic therapy.

Conclusions:

• Significant advancements have been made in preventing and treating cardioembolic strokes.
• New technologies and therapies offer more personalized stroke risk management.
• Careful assessment of bleeding versus clotting risk is crucial in antithrombotic therapy selection.